Clinical Trials Directory

Trials / Completed

CompletedNCT00888290

Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Albert Einstein College of Medicine · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study will enroll 25 patients with kidney disease to evaluate the effects of different doses of sodium bicarbonate (baking soda) on levels of bicarbonate in the blood, kidney function and muscle strength. The investigators will also evaluate safety and tolerability of different doses.

Detailed description

This study enrolled 20 patient to evaluate the effects of different doses of sodium bicarbonate. We will test serum bicarbonate levels, potassium levels and muscle function.

Conditions

Interventions

TypeNameDescription
DRUGSodium bicarbonateSodium bicarbonate at 3 different doses or placebo. The different doses tested will be: 0.3 mEq/kg of ideal body weight, 0.6 mEq/kg of ideal body weight and 1 mEq/kg pf ideal body weight
DRUGPlacebosPlacebo at 3 different doses to match Sodium bicarbonate dosing

Timeline

Start date
2009-03-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2009-04-27
Last updated
2022-08-30
Results posted
2022-08-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00888290. Inclusion in this directory is not an endorsement.